Head and neck surgery during the coronavirus‐19 pandemic: The University of California San Francisco experience

Wai, Katherine C.; Xu, Mary Jue; Lee, Rex H.; El‐Sayed, Ivan H.; George, Julia D.; Heaton, Chase M.; Knott, P. Daniel; Park, Andrea M.; Ryan, William R.; Seth, Rahul; Ha, Patrick K.

doi:10.1002/hed.26514

Cited by 17 publications

(45 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results of this study are in concordance with the data from most other centres 18 , 19 , which clearly show that the postoperative outcomes remain unchanged with no added risk or a minimal risk of SARS-CoV-2 infections in healthcare personnel. Iyer et al reported that there was a reduction in number of cases (overall operative caseload) to about 60% of the pre-COVID-19 times in order to maintain adequate safety and implement protective measures for COVID-19 transmission 20 .…”

Section: Discussionsupporting

confidence: 90%

Increased tracheostomy rates in head and neck cancer surgery during the COVID-19 pandemic

Batra

Tilak

Pai

et al. 2020

International Journal of Oral and Maxillofacial Surgery

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 90%

Increased tracheostomy rates in head and neck cancer surgery during the COVID-19 pandemic

Batra

Tilak

Pai

et al. 2020

International Journal of Oral and Maxillofacial Surgery

View full text Add to dashboard Cite

“…40 Performing a preoperative nasopharyngeal swab in all patients with HNC was done to reduce the possibility of perioperative complications and to keep hospitals safe for other patients and staff. [41][42][43] HNCs arise from mucosal membranes and the diagnosis and treatment often involve potential viral exposure, dysphagia or airway compromise, and nasogastric or tracheotomy tubes, all factors potentially exposing health care providers to aerosolized virus. 41,44 In this scenario, social distancing and personal hygiene are mandatory to avoid spread of COVID-19.…”

Section: Discussionmentioning

confidence: 99%

Outcomes of head and neck cancer management from two cancer centres in Southern and Northern Europe during the first wave of COVID-19

Tagliabue

Russell

Moss

et al. 2021

Tumori

View full text Add to dashboard Cite

Objective: To describe the approach and outcomes from two cancer centres in Southern and Northern Europe during the first wave of coronavirus disease 2019 (COVID-19) of patients with head and neck cancer (HNC). Methods: Data collection was performed on a retrospective cohort of patients surgically treated for primary HNC between March and May 2020, using data from two tertiary hospitals: the European Institute of Oncology (Milan) and Guy’s & St Thomas’ NHS Foundation Trust (London). Results: We included 77 patients with HNC. More patients with COVID-19 were taking angiotensin-converting enzyme (ACE) inhibitors and had Clavien-Dindo Classification grade I compared to negative patients, respectively (60% vs 22% [ p = 0.058] and 40% vs 8% [ p = 0.025]). Multivariate logistic regression analyses confirmed our data ( p = 0.05 and 0.03, respectively). Sex and age were statistically significantly different ( p = 0.05 and <0.001 respectively), showing more male patients (75% vs 53.66%, respectively) and more elderly patients in Italy than in the United Kingdom (patients aged >63 years: 69.44% vs 29.27%). Conclusions: This study presents a large cohort of patients with HNC with nasopharyngeal swab during the first peak of the COVID-19 pandemic in Europe. Patients with HNC with COVID-19 appeared more likely to develop postsurgical complications and to be taking ACE inhibitors. The preventive measures adopted guaranteed the continuation of therapeutic surgical intervention.

show abstract

“…1 Flowchart of study selection process to an operated case of PTC [20], one regarding potential surgical candidates who underwent active surveillance [21]. Nine English language studies had appropriate data for systematic review [22][23][24][25][26][27][28][29][30].…”

Section: Study Selectionmentioning

confidence: 99%

“…These studies were performed across several countries: three in China [23,27,28], three in Italy [25,29,30], one in USA [26], one in Jordan [22], while the remaining one enrolled a cohort of patients from 26 countries [24]. They were seven single-center observational cohort studies [22,23,[25][26][27][28][29] and two were multi-center studies [24,30], all with a retrospective study design except for two prospective studies [24,28]. Overall, the studies took place between January and August 2020 in countries with community SARS-CoV-2 prevalence varying from low to high.…”

Section: Systematic Reviewmentioning

confidence: 99%

“…The size of the primary lesion could vary from occult [22] to more than 40 mm [22,24,27]. Screening protocols for SARS-CoV-2 detection in hospitalized patients could be based only on COVID-19-related symptoms [22,26] or on also swab and blood tests [25,30] and chest computed tomography (CT) [23,24,[27][28][29]. Personal protection equipment consisting of N95 masks, eye protection, gloves, and gowns was adopted by medical staff in all the studies.…”

Section: Systematic Reviewmentioning

confidence: 99%

See 1 more Smart Citation

Thyroid surgery during the COVID-19 pandemic: results from a systematic review

Scappaticcio

Maiorino

Iorio

et al. 2021

J Endocrinol Invest

View full text Add to dashboard Cite

Purpose During the COVID-19 pandemic, elective thyroid surgery is experiencing delays. The problem is that the COVID-19 pandemic is ongoing. The research purposes were to systematically collect the literature data on the characteristics of those thyroid operations performed and to assess the safety/risks associated with thyroid surgery during the COVID-19 pandemic. Methods We used all the procedures consistent with the PRISMA guidelines. A comprehensive literature in MEDLINE (PubMed) and Scopus was made using ‘‘Thyroid’’ and “coronavirus” as search terms. Results Of a total of 293 articles identified, 9 studies met the inclusion criteria. The total number of patients undergoing thyroid surgery was 2217. The indication for surgery was malignancy in 1347 cases (60.8%). Screening protocols varied depending on hospital protocol and maximum levels of personal protection equipment were adopted. The hospital length of stay was 2–3 days. Total thyroidectomy was chosen for 1557 patients (1557/1868, 83.4%), of which 596 procedures (596/1558, 38.3%) were combined with lymph node dissections. Cross-infections were registered in 14 cases (14/721, 1.9%), of which three (3/721, 0.4%) with severe pulmonary complications of COVID-19. 377 patients (377/1868, 20.2%) had complications after surgery, of which 285 (285/377, 75.6%) hypoparathyroidism and 71 (71/377, 18.8%) recurrent laryngeal nerve injury. Conclusion The risk of SARS-CoV-2 transmission after thyroid surgery is relatively low. Our study could promote the restart of planned thyroid surgery due to COVID-19. Future studies are warranted to obtain more solid data about the risk of complications after thyroid surgery during the COVID-19 era.

show abstract

Head and neck surgery during the coronavirus‐19 pandemic: The University of California San Francisco experience

Abstract: Background: Guidelines regarding head and neck surgical care have evolved during the coronavirus-19 (COVID-19) pandemic. Data on operative management have been limited. Methods: We compared two cohorts of patients undergoing head and neck or

Cited by 17 publications

References 22 publications

Increased tracheostomy rates in head and neck cancer surgery during the COVID-19 pandemic

Increased tracheostomy rates in head and neck cancer surgery during the COVID-19 pandemic

Outcomes of head and neck cancer management from two cancer centres in Southern and Northern Europe during the first wave of COVID-19

Thyroid surgery during the COVID-19 pandemic: results from a systematic review

Contact Info

Product

Resources

About